Skip to Content
Merck
  • Patient-derived three-dimensional cortical neurospheres to model Parkinson's disease.

Patient-derived three-dimensional cortical neurospheres to model Parkinson's disease.

PloS one (2022-12-02)
Waseem K Raja, Esther Neves, Christopher Burke, Xin Jiang, Ping Xu, Kenneth J Rhodes, Vikram Khurana, Robert H Scannevin, Chee Yeun Chung
ABSTRACT

There are currently no preventive or disease-modifying therapies for Parkinson's Disease (PD). Failures in clinical trials necessitate a re-evaluation of existing pre-clinical models in order to adopt systems that better recapitulate underlying disease mechanisms and better predict clinical outcomes. In recent years, models utilizing patient-derived induced pluripotent stem cells (iPSC) have emerged as attractive models to recapitulate disease-relevant neuropathology in vitro without exogenous overexpression of disease-related pathologic proteins. Here, we utilized iPSC derived from patients with early-onset PD and dementia phenotypes that harbored either a point mutation (A53T) or multiplication at the α-synuclein/SNCA gene locus. We generated a three-dimensional (3D) cortical neurosphere culture model to better mimic the tissue microenvironment of the brain. We extensively characterized the differentiation process using quantitative PCR, Western immunoblotting and immunofluorescence staining. Differentiated and aged neurospheres revealed alterations in fatty acid profiles and elevated total and pathogenic phospho-α-synuclein levels in both A53T and the triplication lines compared to their isogenic control lines. Furthermore, treatment of the neurospheres with a small molecule inhibitor of stearoyl CoA desaturase (SCD) attenuated the protein accumulation and aberrant fatty acid profile phenotypes. Our findings suggest that the 3D cortical neurosphere model is a useful tool to interrogate targets for PD and amenable to test small molecule therapeutics.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-S-100 (β-Subunit) antibody produced in mouse, clone SH-B1, ascites fluid
Sigma-Aldrich
Anti-HNK-1/N-CAM (CD57) antibody, Mouse monoclonal, clone VC1.1, purified from hybridoma cell culture
Sigma-Aldrich
Anti-GAD67 Antibody, clone 1G10.2, clone 1G10.2, Chemicon®, from mouse
Sigma-Aldrich
Anti-Brn-2 (POU3F2) Antibody, clone 8C4.2, clone 8C4.2, from mouse
Sigma-Aldrich
Anti-Tbr1 Antibody, from chicken, purified by affinity chromatography